US2016250201A1PendingUtilityA1
Device and method for delivery of a medicament
Est. expiryMar 30, 2027(~0.7 yrs left)· nominal 20-yr term from priority
A61P 9/10A61P 9/06A61P 43/00A61P 9/00A61P 3/04A61P 25/28A61P 25/34A61P 25/16A61P 25/00A61P 1/04A61P 11/06A61M 2205/8206A61K 31/4439A61M 15/06A61M 11/047A61K 9/007A61K 9/1617A24B 15/167A61M 2205/071A61M 11/041A61M 15/009A61M 15/0091A24F 47/002A61K 31/465A24F 40/40A24F 42/60A24F 42/20A24F 42/10A24F 40/10A24B 15/16A24F 40/42
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure relates to a method of enhancing nicotine or other medicament concentrations in a gaseous carrier. The methods are adaptable to the delivery of nicotine or other medicaments for therapeutic effect in various diseases, in particular nicotine for tobacco product use cessation, substitution and/or harm reduction. The disclosure further relates various devices and device design principles for practicing these methods.
Claims
exact text as granted — not AI-modified1 - 48 . (canceled)
49 . A method for delivering a medicament to a user, the method comprising:
passing a gaseous stream over a first substance to create a first vapor- containing gaseous stream; passing the first vapor-containing gaseous stream over a second substance to create particles in the gaseous stream; and delivering the gaseous stream containing the particles to a user.
50 . The method according to claim 49 , wherein the passing a gaseous stream over a first substance step comprises capturing a vapor of the first substance in the gaseous stream.
51 . The method according to claim 49 , wherein the step of creating particles comprises contacting a vapor of the second substance with the first vapor-containing gaseous stream.
52 . The method according to claim 49 , wherein the method steps occur at a temperature of 100 degrees Celsius or less.
53 . The method according to claim 49 , wherein the step of creating the particles comprises an interaction between the first and second substances.
54 . The method according to claim 53 , wherein the interaction comprises an acid-base reaction.
55 . The method according to claim 49 , wherein the first and second substances are volatile substances.
56 . The method according to claim 49 , wherein one of the first substance and the second substance comprises nicotine.
57 . The method according to claim 56 , wherein the nicotine comprises free base nicotine.
58 . The method according to claim 49 , wherein the particles comprise nicotine-containing particles.
59 . The method according to claim 49 , wherein the particles comprise nicotine salt particles.
60 . The method according to claim 49 , wherein the particles comprise nicotine pyruvate.
61 . The method according to claim 49 , wherein at least some of the particles are visible particles.
62 . The method according to claim 49 , wherein the particles are less than 6 microns in diameter.
63 . The method according to claim 49 , wherein at least some of the particles are between 0.5 and 5 microns in diameter.
64 . The method according to claim 49 , wherein the second substrate comprises nicotine.
65 . The method according to claim 64 , wherein the first substance comprises an organic acid.
66 . The method according to claim 64 , wherein the first substance comprises pyruvic acid.
67 . The method according to claim 64 , wherein the nicotine comprises free base nicotine.
68 . The method according to claim 66 , wherein the method steps occur at a temperature of 40±5 degrees Celsius.Join the waitlist — get patent alerts
Track US2016250201A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.